Innogen Pharma and Unit Invest 125 Million Yuan in Bank of Ningbo Structured Products; Shares Slip 2%

MT Newswires Live

2025/12/02

Guangzhou Innogen Pharmaceutical (HKG:2591) and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo (SHE:002142), according to a Monday Hong Kong bourse filing.

Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.

The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.

The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.

Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/news/2588086329"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2588086329\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2588086329?lang=zh_CN&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-12-02 12:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2588086329","market":"hk","top_or_hot":-1,"title":"Innogen Pharma and Unit Invest 125 Million Yuan in Bank of Ningbo Structured Products; Shares Slip 2%","media":"MT Newswires Live","content":"<html><body><p> Guangzhou Innogen Pharmaceutical (HKG:2591) and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo (SHE:002142), according to a Monday Hong Kong bourse filing.</p><p>Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.</p><p>The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.</p><p>The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.</p><p>Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Innogen Pharma and Unit Invest 125 Million Yuan in Bank of Ningbo Structured Products; Shares Slip 2%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nInnogen Pharma and Unit Invest 125 Million Yuan in Bank of Ningbo Structured Products; Shares Slip 2%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2025-12-02 12:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Guangzhou Innogen Pharmaceutical (HKG:2591) and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo (SHE:002142), according to a Monday Hong Kong bourse filing.</p><p>Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.</p><p>The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.</p><p>The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.</p><p>Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0201","symbol_name":"可转债","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2588086329","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2588086329","pubTimestamp":1764648224,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Guangzhou Innogen Pharmaceutical  and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo , according to a Monday Hong Kong bourse filing.Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK0201":"可转债","LU1720050803.USD":"安联全方位中国股票基金","LU2580892789.USD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (USD) ACC","BK1161":"生物科技","LU1688375341.USD":"贝莱德中国灵活股票基金","LU2097828557.USD":"AZ EQUITY CHINA \"A\" (USD) ACC","LU2097828631.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC","LU1794554557.SGD":"Allianz All China Equity AT Acc H2-SGD","LU2097828714.EUR":"AZ EQUITY CHINA \"BAZ\" (EUR) ACC","BK0278":"货币金融","LU2580892862.HKD":"FRANKLIN SEALAND CHINA A-SHARES \"A\" (HKD) ACC","BK0197":"中小创蓝筹","LU1969619763.USD":"EASTSPRING INV CHINA A SHARES GROWTH \"A\" (USD) ACC","LU2097828805.USD":"AZ EQUITY CHINA \"A-AZ\" (USD) ACC","LU1146622755.USD":"安本中国A股股票基金A Acc","SGXZ81163826.USD":"UNITED CHINA A-SHARES INNOVATION \"A\" (USD) ACC","SGXZ49509284.SGD":"United China A Shares Innovation A Acc SGD","LU0140636845.USD":"施罗德大中华区股票A Acc","LU2097828474.EUR":"AZ EQUITY CHINA \"A\" (EUR) ACC A","02591":"银诺医药-B","BK0183":"MSCI概念","BK0188":"融资融券","LU1820825898.SGD":"Aberdeen Standard SICAV I - China A Share Equity A Acc SGD-H","KTH":"Corts Trust Peco Energy Capital Trust III","BK0187":"一线龙头","LU1655091616.SGD":"JPMorgan Funds - China A-Share Opportunities A (acc) SGD","002142":"宁波银行","BK0028":"国家队","LU2328871848.SGD":"Eastspring Investments - China A Shares Growth AS SGD"},"translate_title":"Innogen Pharma和Unit投资宁波银行结构性产品1.25亿元；股价下跌2%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KTH":1.5,"002142":0.9,"02591":1},"content_text":"Guangzhou Innogen Pharmaceutical (HKG:2591) and its wholly owned unit Innogen Technology subscribed to a combined 125 million yuan in structured deposit products issued by Bank of Ningbo (SHE:002142), according to a Monday Hong Kong bourse filing.Shares of the pharmaceutical firm were down nearly 2% in Tuesday's late morning trade.The parent company subscribed to 75 million yuan, and the subsidiary to 50 million yuan.The subscriptions were funded with internal resources and made after earlier Bank of Ningbo products matured on Nov. 26, the filing said.Innogen said the deposits form part of its treasury management strategy to generate returns on idle cash while maintaining sufficient working capital.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"shareholding","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"}}}